Graham Jackson, MD, PhD

home / authors / graham-jackson-md-phd

Articles

Dr. Jackson on Ongoing Challenges in Treating Patients With Multiple Myeloma

March 24th 2017

Graham Jackson, MD, PhD, Northern Institute for Cancer Research, Newcastle University, discusses some of the ongoing challenges in the treatment of patients with multiple myeloma.

Dr. Jackson on the Toxicity Profile of Lenalidomide Maintenance in Myeloma

Graham Jackson, MD, PhD

February 9th 2017

Graham Jackson, MD, PhD, Northern Institute for Cancer Research, Newcastle University, discusses the toxicity profile of lenalidomide maintenance therapy in the treatment of patients with multiple myeloma.

Dr. Jackson on Benefits of Maintenance Therapy for Myeloma

Graham Jackson, MD, PhD

January 18th 2017

Graham Jackson, MD, PhD, Northern Institute for Cancer Research, Newcastle University, discusses the benefits of maintenance therapy for patients with multiple myeloma.

Dr. Jackson on Lenalidomide as a Highly-Effective Maintenance Therapy in Myeloma

Graham Jackson, MD, PhD

December 7th 2016

Graham Jackson, MD, PhD, Northern Institute for Cancer Research, Newcastle University, discusses results of a study that determined lenalidomide (Revlimid) is a highly-effective maintenance therapy in myeloma patients of all ages.